Cite
HARVARD Citation
Sellam, J. et al. (2017). Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis research & therapy. 19 (1), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sellam, J. et al. (2017). Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis research & therapy. 19 (1), p. 1. [Online].